
High levels of vitamin D may help slow the progression of breast cancer, researchers suggested Tuesday.
A small study of women with the illness found that patients with early breast cancer had higher levels of the vitamin than those with more advanced disease.
"Vitamin D levels are lower in women with advanced breast cancer than in early breast cancer," said Carlo Palmieri, of Imperial College in London.
"It lends support to the idea that vitamin D has a role in the progression of breast cancer," he told Reuters.
The researchers measured the amount of vitamin D in blood samples from 279 women with breast cancer. In 204 women, the disease was in its early stages. It was more advanced in the other 75.
"We know from previous studies that breast cancer incidence is higher in women who live in higher latitudes and have less sun exposure," said Palmieri.
Vitamin D, the so-called sunshine vitamin, is found in fortified milk and dairy products, cod liver oil, and some fatty fish.
The body produces vitamin D in the skin when it is exposed to sunlight. Laboratory tests have also shown that vitamin D can stop cancer cells from dividing.
Breast cancer is the most common cancer in women, with more than a million cases detected worldwide each year, according to the International Agency for Research on Cancer (IARC) in Lyon, France. The earlier the cancer is detected and treated, the greater the chances of survival.
Although the scientists do not know whether the low levels of vitamin D are a cause or a consequence of the cancer, their findings and the results of other studies suggest that low levels of vitamin D may be involved in the progression of early breast cancer to more advanced stages.
"The next thing in this research is to try and understand the potential causes and mechanisms underlying these differences and the precise consequences at a molecular level," said Palmieri, who reported the finding in the Journal of Clinical Pathology.
"We also need to look at the potential clinical implications of monitoring and maintaining high circulating vitamin D levels in breast cancer patients," he added in a statement.
Breast cancer is treated with surgery and radiotherapy, chemotherapy, and hormone treatment, or a combination of these, depending on the cancer and stage of the illness.
Factors that can increase a woman's risk of breast cancer include having a mother or close relative with the disease, inherited mutations in the BRCA1 or BRCA2 genes, an early puberty, late menopause, and not having any children. (Reuters)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.